ePrints

Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Lookup NU author(s): Giovany Orozco LealORCiD, Nigel Armstrong, Dr Ashleigh KernohanORCiD, Dr Diarmuid CoughlanORCiD, Tomos Robinson, Professor Luke ValeORCiD

Downloads

• Accepted version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Orozco leal G, Armstrong N, Kernohan A, Ahmadu C, Coughlan D, McDermott K, Duffy S, O'Meara S, Robinson T, Vale L, Kleijnen J

Publication type: Article

Publication status: Published

Journal: PharmacoEconomics

Year: 2023

Volume: 41

Issue: 7

Pages: 741-750

Print publication date: 01/07/2023

Online publication date: 23/03/2023

Acceptance date: 23/02/2023

Date deposited: 17/08/2023

ISSN (print): 1170-7690

ISSN (electronic): 1179-2027

Publisher: Adis International Ltd.

URL: https://doi.org/10.1007/s40273-023-01259-6

DOI: 10.1007/s40273-023-01259-6

ePrints DOI: 10.57711/9vsj-sa35

Altmetrics

Funding

Share